24 related articles for article (PubMed ID: 38575432)
1. DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer.
Petkar I; Rooney K; Roe JW; Patterson JM; Bernstein D; Tyler JM; Emson MA; Morden JP; Mertens K; Miles E; Beasley M; Roques T; Bhide SA; Newbold KL; Harrington KJ; Hall E; Nutting CM
BMC Cancer; 2016 Oct; 16(1):770. PubMed ID: 27716125
[TBL] [Abstract][Full Text] [Related]
2. The changing therapeutic landscape of head and neck cancer.
Cramer JD; Burtness B; Le QT; Ferris RL
Nat Rev Clin Oncol; 2019 Nov; 16(11):669-683. PubMed ID: 31189965
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Office-Based Salivary Ductal Steroid Irrigation for Managing Post-Irradiation Xerostomia in Head and Neck Cancer Patients: A Retrospective Study.
Chen YC; Viet-Nhi NK; Dang LH; Su CH; Hung SH
Biomedicines; 2024 May; 12(5):. PubMed ID: 38790995
[TBL] [Abstract][Full Text] [Related]
4. Technical advances and pitfalls in head and neck radiotherapy.
Parvathaneni U; Laramore GE; Liao JJ
J Oncol; 2012; 2012():597467. PubMed ID: 22701482
[TBL] [Abstract][Full Text] [Related]
5. Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial.
Gupta T; Sinha S; Ghosh-Laskar S; Budrukkar A; Mummudi N; Swain M; Phurailatpam R; Prabhash K; Agarwal JP
Radiat Oncol; 2020 Sep; 15(1):218. PubMed ID: 32938468
[TBL] [Abstract][Full Text] [Related]
6. Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial.
Tao Y; Auperin A; Blanchard P; Alfonsi M; Sun XS; Rives M; Pointreau Y; Castelli J; Graff P; Wong Hee Kam S; Thariat J; Veresezan O; Heymann S; Renard-Oldrini S; Lafond C; Cornely A; Casiraghi O; Boisselier P; Lapeyre M; Biau J; Bourhis J
Radiother Oncol; 2020 Sep; 150():18-25. PubMed ID: 32417348
[TBL] [Abstract][Full Text] [Related]
7. Weekly Adaptive Radiotherapy vs Standard Intensity-Modulated Radiotherapy for Improving Salivary Function in Patients With Head and Neck Cancer: A Phase 3 Randomized Clinical Trial.
Castelli J; Thariat J; Benezery K; Hasbini A; Gery B; Berger A; Liem X; Guihard S; Chapet S; Thureau S; Auberdiac P; Pommier P; Ruffier A; Perrier L; Devillers A; Campillo-Gimenez B; de Crevoisier R
JAMA Oncol; 2023 Aug; 9(8):1056-1064. PubMed ID: 37261806
[TBL] [Abstract][Full Text] [Related]
8. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.
Nutting CM; Morden JP; Harrington KJ; Urbano TG; Bhide SA; Clark C; Miles EA; Miah AB; Newbold K; Tanay M; Adab F; Jefferies SJ; Scrase C; Yap BK; A'Hern RP; Sydenham MA; Emson M; Hall E;
Lancet Oncol; 2011 Feb; 12(2):127-36. PubMed ID: 21236730
[TBL] [Abstract][Full Text] [Related]
9. Intensity-Modulated Radiation Therapy Alone Versus Intensity-Modulated Radiation Therapy and Brachytherapy for Early-Stage Oropharyngeal Cancers: Results From a Randomized Controlled Trial.
Budrukkar A; Murthy V; Kashid S; Swain M; Rangarajan V; Laskar SG; Kannan S; Kale S; Upreti R; Pai P; Pantvaidya G; Gupta T; Agarwal JP
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1541-1551. PubMed ID: 37660737
[TBL] [Abstract][Full Text] [Related]
10. Reducing Salivary Toxicity with Adaptive Radiotherapy (ReSTART): A Randomized Controlled Trial Comparing Conventional IMRT to Adaptive IMRT in Head and Neck Squamous Cell Carcinomas.
Ghosh Laskar S; Sinha S; Kumar A; Samanta A; Mohanty S; Kale S; Khan F; Lewis Salins S; Murthy V
Clin Oncol (R Coll Radiol); 2024 Jun; 36(6):353-361. PubMed ID: 38575432
[TBL] [Abstract][Full Text] [Related]
11. [Proton therapy for head and neck squamous cell carcinomas: From physics to clinic].
Beddok A; Vela A; Calugaru V; Tessonnier T; Kubes J; Dutheil P; Gérard A; Vidal M; Goudjil F; Florescu C; Kammerer E; Bénézery K; Hérault J; Bourhis J; Thariat J;
Cancer Radiother; 2019 Sep; 23(5):439-448. PubMed ID: 31358445
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiotherapy: is xerostomia still prevalent?
Chambers MS; Garden AS; Rosenthal D; Ahamad A; Schwartz DL; Blanco AI; Chao KS; Morrison WH; Ang KK; Weber RS
Curr Oncol Rep; 2005 Mar; 7(2):131-6. PubMed ID: 15717947
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
